View in EDS HTML Full Text PDF Full Text

Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study.

Saved in:
Bibliographic Details
Title: Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study.
Authors: Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Hope.Rugo@ucsf.edu., Kabos P; Divisions of Medical Oncology, Department of Medicine, University of Colorado, Anschutz Medical Campus, 12801 East 17th Avenue, Aurora, CO, 80045, USA., Beck JT; Highlands Oncology Group, Fayetteville, AR, USA., Jerusalem G; Laboratory of Medical Oncology, University of Liège, Liège, Belgium.; Department of Medical Oncology, CHU Sart-Tilman Liège, Liège, Belgium., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Sevillano E; Department of Medical Oncology, Centro Integral Oncologico Clara Campal, Madrid, Spain., Paz-Ares L; Hospital Universitario 12 de Octubre, CNIO-H120 Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain., Chisamore MJ; Department of Clinical Research, Merck & Co., Inc., Rahway, NJ, USA., Chapman SC; Eli Lilly and Company, Bracknell, UK., Hossain AM; Eli Lilly and Company, Indianapolis, IN, USA., Chen Y; Eli Lilly and Company, Indianapolis, IN, USA., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Nov 05; Vol. 8 (1), pp. 118. Date of Electronic Publication: 2022 Nov 05.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36335120
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Hope.Rugo@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Kabos+P%22">Kabos P</searchLink>; Divisions of Medical Oncology, Department of Medicine, University of Colorado, Anschutz Medical Campus, 12801 East 17th Avenue, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22Beck+JT%22">Beck JT</searchLink>; Highlands Oncology Group, Fayetteville, AR, USA.<br /><searchLink fieldCode="AU" term="%22Jerusalem+G%22">Jerusalem G</searchLink>; Laboratory of Medical Oncology, University of Liège, Liège, Belgium.; Department of Medical Oncology, CHU Sart-Tilman Liège, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Wildiers+H%22">Wildiers H</searchLink>; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Sevillano+E%22">Sevillano E</searchLink>; Department of Medical Oncology, Centro Integral Oncologico Clara Campal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Paz-Ares+L%22">Paz-Ares L</searchLink>; Hospital Universitario 12 de Octubre, CNIO-H120 Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Chisamore+MJ%22">Chisamore MJ</searchLink>; Department of Clinical Research, Merck & Co., Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chapman+SC%22">Chapman SC</searchLink>; Eli Lilly and Company, Bracknell, UK.<br /><searchLink fieldCode="AU" term="%22Hossain+AM%22">Hossain AM</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2022 Nov 05; Vol. 8 (1), pp. 118. <i>Date of Electronic Publication: </i>2022 Nov 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36335120
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-022-00482-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 118
    Titles:
      – TitleFull: Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Kabos P
      – PersonEntity:
          Name:
            NameFull: Beck JT
      – PersonEntity:
          Name:
            NameFull: Jerusalem G
      – PersonEntity:
          Name:
            NameFull: Wildiers H
      – PersonEntity:
          Name:
            NameFull: Sevillano E
      – PersonEntity:
          Name:
            NameFull: Paz-Ares L
      – PersonEntity:
          Name:
            NameFull: Chisamore MJ
      – PersonEntity:
          Name:
            NameFull: Chapman SC
      – PersonEntity:
          Name:
            NameFull: Hossain AM
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Tolaney SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 11
              Text: 2022 Nov 05
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1